Abacavir, dolutegravir, and lamivudine and Alemtuzumab (Lemtrada)
Determining the interaction of Abacavir, dolutegravir, and lamivudine and Alemtuzumab (Lemtrada) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: abacavir / dolutegravir / lamivudine
Brand name: Triumeq
Synonyms: Abacavir, Dolutegravir, and Lamivudine
Generic Name: alemtuzumab
Brand name: Campath, Lemtrada
Synonyms: Alemtuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abacavir, dolutegravir, and lamivudine-Alemtuzumab Intravenous
- Abacavir, dolutegravir, and lamivudine-Alenaze-D
- Abacavir, dolutegravir, and lamivudine-Alendronate
- Abacavir, dolutegravir, and lamivudine-Alendronate and cholecalciferol
- Abacavir, dolutegravir, and lamivudine-Alendronate Effervescent Tablets
- Abacavir, dolutegravir, and lamivudine-Alendronate Oral Solution
- Alemtuzumab (Lemtrada)-Abacavir, Lamivudine and Zidovudine Tablets
- Alemtuzumab (Lemtrada)-Abacavir, lamivudine, and zidovudine
- Alemtuzumab (Lemtrada)-Abaloparatide
- Alemtuzumab (Lemtrada)-Abaloparatide Subcutaneous
- Alemtuzumab (Lemtrada)-Abatacept
- Alemtuzumab (Lemtrada)-Abatacept Auto-Injectors